Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Ark reports breakthrough in targeted gene therapy delivery

Aug. 10, 2005

In vitro data presented on novel VCAM-1 inhibitor from Novartis

Aug. 3, 2005

Phogen and Cancer Research Technology sign agreement for VP22 technology

Aug. 3, 2005

Aegis signs new deal for Intravail technology

Aug. 3, 2005

Genentech licenses TAP technology for use with therapeutic antibodies

Aug. 1, 2005

Cellzome and Novartis expand pathway research collaboration

July 29, 2005

Evotec and Almirall sign library synthesis agreement

July 25, 2005

Vical begins phase I study of gene-based IL-2 with electroporation

July 21, 2005

Novel adenosine A3 receptor antagonists reported

July 19, 2005

Three-year extension to collaboration between Structural GenomiX and Lilly

July 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...